Scilex Holding Co (SCLX)
0.86
+0.01
(+1.37%)
USD |
NASDAQ |
May 03, 16:00
0.8495
-0.01
(-1.22%)
After-Hours: 20:00
Scilex Total Return Level: 0.86 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 0.86 |
May 02, 2024 | 0.8484 |
May 01, 2024 | 0.8556 |
April 30, 2024 | 0.8532 |
April 29, 2024 | 0.9221 |
April 26, 2024 | 0.8805 |
April 25, 2024 | 0.8608 |
April 24, 2024 | 0.85 |
April 23, 2024 | 0.9767 |
April 22, 2024 | 0.9514 |
April 19, 2024 | 0.8978 |
April 18, 2024 | 0.90 |
April 17, 2024 | 1.17 |
April 16, 2024 | 1.16 |
April 15, 2024 | 1.28 |
April 12, 2024 | 1.33 |
April 11, 2024 | 1.30 |
April 10, 2024 | 1.34 |
April 09, 2024 | 1.36 |
April 08, 2024 | 1.39 |
April 05, 2024 | 1.53 |
April 04, 2024 | 1.53 |
April 03, 2024 | 1.54 |
April 02, 2024 | 1.55 |
April 01, 2024 | 1.57 |
Date | Value |
---|---|
March 28, 2024 | 1.59 |
March 27, 2024 | 1.61 |
March 26, 2024 | 1.51 |
March 25, 2024 | 1.46 |
March 22, 2024 | 1.44 |
March 21, 2024 | 1.40 |
March 20, 2024 | 1.36 |
March 19, 2024 | 1.35 |
March 18, 2024 | 1.37 |
March 15, 2024 | 1.37 |
March 14, 2024 | 1.39 |
March 13, 2024 | 1.33 |
March 12, 2024 | 1.32 |
March 11, 2024 | 1.40 |
March 08, 2024 | 1.42 |
March 07, 2024 | 1.39 |
March 06, 2024 | 1.36 |
March 05, 2024 | 1.31 |
March 04, 2024 | 1.34 |
March 01, 2024 | 1.335 |
February 29, 2024 | 2.27 |
February 28, 2024 | 2.42 |
February 27, 2024 | 2.31 |
February 26, 2024 | 2.07 |
February 23, 2024 | 1.75 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.8484
Minimum
May 02 2024
14.80
Maximum
Apr 12 2023
4.355
Average
3.44
Median
Total Return Level Benchmarks
Sorrento Therapeutics Inc | 0.015 |
Adial Pharmaceuticals Inc | 1.70 |
Precision BioSciences Inc | 10.52 |
Humacyte Inc | 4.41 |
Perspective Therapeutics Inc | 1.81 |